top of page
Vim (formerly Spire)
Technology
SaaS Platforms
Provider Enablement / EHR Workflow Platform
Won by embedding care-gap alerts and quality-measure prompts directly into the EHR workflows physicians already use — eliminating the separate login and separate screen that caused every prior population-health tool to be ignored.
1
MODEL
BUSINESS MODEL
SaaS, Infrastructure Platform
model bm
HOW THEY BUILT IT
- Founded as Spire Health; rebranded to Vim as the company pivoted from wearable health monitoring toward provider-network enablement.
- Core product: EHR-embedded point-of-care alerting that surfaces care-gap closures, prior-authorization shortcuts, and quality-measure opportunities inside the physician's existing EHR (Epic, Athena, NextGen) without requiring a separate login.
- Revenue model: health plans and risk-bearing provider organisations pay per-physician or per-attributed-patient for the embedded workflow layer.
HOW TO ARCHITECT IT
1. In healthcare IT, if your tool requires a separate login from the EHR, assume it will not be used — every workflow tool must live inside the existing EHR interface to achieve clinical adoption.
2. Sell to the health plan or risk-bearing entity that benefits financially from care-gap closure, not to the physician who bears the burden of a new tool.
3. Build EHR integrations as the primary technical barrier — Epic certification and Athena integration take 12+ months and create competitive moat.
4. Price on outcomes (care gaps closed, quality measures captured) rather than seats, aligning revenue with the payer's financial interest.
DISTRIBUTION MODEL
Enterprise Sales, B2B Platform Distribution
dm
HOW THEY OPERATIONALIZED
- Direct enterprise sales to health plan medical directors and value-based care operations teams who control the budget for provider-network quality improvement.
- EHR integration certifications (Epic App Orchard, Athena Marketplace) provide a regulated distribution channel where physicians discover Vim when their practice is activated by a health plan.
- Health system and IPA partnerships provide population-level deployment across all affiliated physicians simultaneously.
HOW TO REPLICATE WHAT WORKED
What worked: selling to the health plan that pays for adoption rather than asking the physician to adopt another tool — the B2B2C motion where the payer funds deployment into the physician's existing EHR.
The trap: health plan sales cycles are 12–24 months, procurement is complex (medical affairs, IT, legal, contracting), and the physician end-user has no purchasing power — a company with thin runway cannot afford this sales motion.
| PATTERNS OF THIS MODEL
PATTERNS IN WORKFLOW LAYERS INSIDE CLINICAL SYSTEMS OF RECORD:
1. IF A TOOL REQUIRES A SEPARATE LOGIN FROM THE SYSTEM OF RECORD, ASSUME IT WILL NOT BE USED. Clinical adoption depends on living inside the existing interface.
2. SELL TO THE PARTY THAT BENEFITS FINANCIALLY, NOT THE ONE BEARING THE BURDEN. The practitioner absorbs the effort; the risk-bearing entity captures the value.
3. DEEP INTEGRATIONS ARE THE COMPETITIVE MOAT PRECISELY BECAUSE THEY TAKE A YEAR OR MORE. Certification timelines protect whoever completes them first.
4. PRICE ON OUTCOMES CAPTURED, NOT SEATS, aligning revenue with the payer's financial interest rather than headcount.
What companies with this model reveal
| OPPORTUNITY INTELLIGENCE
GOLDMINE 1 — IF IT NEEDS A SEPARATE LOGIN, IT WILL NOT BE USED.
Standard: in healthcare IT, any workflow tool must live inside the existing EHR interface to achieve clinical adoption. This is the single most transferable rule in provider software.
GOLDMINE 2 — SELL TO WHOEVER BENEFITS FINANCIALLY, NOT WHOEVER BEARS THE BURDEN.
Standard: health plans and risk-bearing organisations gain from care-gap closure; the physician only gains work. Charge the beneficiary.
GOLDMINE 3 — MAKE THE INTEGRATION THE BARRIER TO ENTRY.
Standard: Epic certification and Athena integration take 12+ months. Slow, expensive integration work is a moat precisely because it cannot be rushed.
THE PIT — A HEALTH-WEARABLE COMPANY BECAME A PROVIDER-ENABLEMENT COMPANY.
The Spire-to-Vim pivot discarded the original product, brand and market entirely. Consumer health hardware to B2B2C infrastructure is a total restart, and the only asset that transferred was the team.
THE SECOND PIT — YOUR PRODUCT IS AN OVERLAY ON EHRs THAT CAN CLOSE THE INTERFACE.
MOVE WITH CAUTION — OUTCOME PRICING MEANS PROVING ATTRIBUTION IN A SYSTEM YOU DON'T CONTROL.
Untapped Business Model / Gaps / Goldmines / Pits
Patterns & Insights
2
MARKET
mkt mt es
MARKET TYPE
Emerging Market
WHY THEY WON
Value-based care enablement at the point of care — specifically EHR-embedded care-gap tools — was an emerging market driven by the shift from fee-for-service to value-based contracts in US commercial and Medicare Advantage insurance. Incumbents (Arcadia, Lightbeam, Health Catalyst) operated as population-health analytics platforms requiring separate logins, creating the embedded workflow gap that Vim targeted.
ENTRY STRATEGY
Greenfield Entry
EXECUTION
No prior tool offered EHR-embedded point-of-care alerting as a health-plan-funded distribution model; Vim entered this design philosophy as a genuine greenfield, building the EHR integration infrastructure from scratch rather than reskinning an existing population-health analytics dashboard.
FOOTHOLD STRATEGY
fs
Lighthouse Customer Strategy
Vim's sales strategy required a named health-plan reference customer to break the 'too new for clinical deployment' objection — a credible regional or national payer willing to fund the first large-scale physician-network deployment. That lighthouse customer's outcomes data (care gaps closed per physician per month) became the primary sales collateral for every subsequent health plan prospect.
GROWTH CAMPAIGN
CAMPAIGNS THAT WORKED
- Outcomes-based case studies quantifying care gaps closed per provider per month, published for health plan audiences at AHIP and ViVE conferences.
- EHR vendor partnership announcements (Epic App Orchard certification) as credibility signals to health plan IT teams evaluating integration complexity.
- Thought leadership on the 'physician workflow tax' — the productivity cost of requiring clinicians to use tools outside their EHR.
KEY LEARNING
In healthcare IT, clinical adoption is the product — a tool that physicians use 80% of the time at point-of-care delivers 8x the value of a tool they check once a week in a separate portal. Every product decision should be evaluated against 'does this reduce or increase the number of clicks a physician makes before they see your alert?' Zero additional clicks is the only clinically viable design target.
gc
Market Context
| MARKET INTELLIGENCE
THE STANDARD: When incumbents require the user to leave their primary system, embedding into that system is a structural advantage no analytics depth overcomes.
RULE 1 — A SEPARATE LOGIN IS A WORKFLOW TAX NOBODY PAYS. Population health platforms produced insight physicians never opened.
RULE 2 — POINT OF CARE IS THE ONLY MOMENT THAT CHANGES BEHAVIOUR. A care gap surfaced during the visit is acted on; a report is not.
RULE 3 — EHR INTEGRATION IS THE MOAT BECAUSE IT IS PAINFUL. Multi-vendor certification and access is slow, expensive and excludes fast followers.
RULE 4 — YOUR REVENUE DEPENDS ON A CONTRACTING MODEL SHIFT YOU DON'T CONTROL. Value-based care adoption pace sets your market size.
MARKET TYPE: Emerging Market (point-of-care value-based care enablement).
| MARKET ENTRY PLAYBOOK
THE STANDARD: WHEN THE USER WILL NOT ADOPT A NEW APPLICATION, EMBED INSIDE THE ONE THEY CANNOT AVOID.
RULE 1 — GO WHERE THE DECISION HAPPENS, NOT WHERE THE DATA LIVES.
Analytics dashboards are read after the fact; in-workflow alerts at the point of care change the decision itself.
RULE 2 — LET THE PARTY WITH THE FINANCIAL INCENTIVE PAY.
Clinicians will not buy this; health plans that capture the savings will. Identify who banks the outcome and invoice them.
RULE 3 — EHR INTEGRATION IS THE MOAT AND THE MULTI-YEAR COST.
Building across fragmented, defensive record systems is exactly what deters better-funded entrants.
How to enter
| FOOTHOLD STRATEGY PLAYBOOK
THE STANDARD: Against a percentage take rate, a flat per-transaction fee is arithmetic the merchant does in his head. The arithmetic is the entire pitch.
SEQUENCE:
1. Price flat against the incumbent's percentage and publish the weekly saving.
2. Specialise in one category so product, marketing and supply all compound.
3. Add the operational products so you become infrastructure, not a channel.
WORKED: A verifiable savings calculation requiring no feature comparison — roughly $500+/week saved at modest order volume.
CAUTION:
1. ECONOMICS DON'T BEAT CONSUMER HABIT. If demand stays with the incumbent marketplace, the merchant runs you for margin and them for volume — capping your share of wallet even among loyal partners.
2. FLAT FEES CAP YOUR UPSIDE as basket sizes rise. You chose the opposite exposure to a take rate.
How to get the first strong position
MARKET PATTERNS & PLAYBOOK
3
MONEY
money rev pri
REVENUE MODEL
Subscription, Performance Fees
PRICING MODEL
Usage-Based Pricing, Value-Based Pricing, Performance Fees
WHY THEY WON
Per-physician-per-month subscriptions paid by the health plan for embedded activation across its attributed physician network. Performance-based components in some contracts tie a portion of Vim's revenue to care-gap closure rates, aligning vendor and payer incentives.
Per-physician pricing scales with the health plan's network size. Performance pricing components are negotiated individually based on the health plan's quality measure contract structure (HEDIS, Star Ratings). Larger network deployments receive volume discounts.
TARGET AUDIENCE
CUSTOMER BUYING BEHAVIOUR
tg cb
Medical directors and VP-level value-based care operations leaders at commercial health plans, Medicare Advantage plans, and risk-bearing provider organisations (IPAs, ACOs) with attributed physician networks of 500+.
Committee-led, long-cycle procurement (medical affairs, IT, legal, network contracting), triggered by a quality-measure performance gap against Medicare Advantage Star Rating targets or HEDIS benchmarks. Sales cycle 12–24 months; decision driven by projected ROI on quality bonus payments.
| PRICING INTELLIGENCE
What makes this model effective & make customers pay
In healthcare, price on the action taken, not the software installed. Value only exists when a clinician changes a decision.
RULE 1 — PERFORMANCE FEES ALIGN WITH PAYERS WHO ONLY VALUE REALISED SAVINGS.
Referral steering and care-gap closure are measurable events. Charging per completed action removes the ROI argument entirely.
RULE 2 — SITTING INSIDE THE EHR WORKFLOW IS THE WHOLE PRODUCT.
Clinicians will not open another application. Zero-new-habit delivery is the only viable adoption path in clinical settings.
RULE 3 — THE PAYER PAYS AND THE PROVIDER USES, WHICH IS A PERMANENT ADOPTION RISK.
Value depends on people who are not your customer changing behaviour.
RULE 4 — EHR VENDOR DEPENDENCE IS THE STRUCTURAL EXPOSURE.
Integration depth is both the moat and the mortality risk, exactly as in any middleware layer.
A payer is buying avoided cost measured in claims data they already hold. Outcome pricing works here because both sides can see the number — which is rare enough that most healthcare software still cannot use it.
PRICE & REVENUE
| Revenue Risk - The biggest threat to revenue stability
Per-physician-per-month pricing paid by a health plan concentrates revenue into a small number of payer contracts, each renegotiable and each a full procurement.
Performance-based components align incentives and hand revenue recognition to the customer's measurement of care-gap closure — a collection risk with no clean escalation.
Value depends on embedding into EHRs you do not control; access policy changes reach the product directly.
Healthcare sales cycles are long, and pilots frequently do not convert to network-wide deployment.
No revenue, ARR or contract values published.
Where the model can break
4
MOTION
LinkedIn: https://www.linkedin.com/company/vim-health, Twitter: https://twitter.com/getvim
GROWTH EXPANSION MODEL
COMPETITIVE STRATEGY
motion ge cs
Geographic Expansion, Horizontal Expansion
HOW THEY EXPAND
After establishing regional health plan customers, Vim's expansion path is into national payers (Aetna, Cigna, Humana) whose nationwide attributed physician networks provide 10x–100x revenue scale from a single contract. Horizontal expansion into additional EHR platforms expands the addressable physician base.
Differentiation, Bypass Attack
HOW THEY COMPETE
Rather than competing with population-health incumbents (Arcadia, Lightbeam) on analytics dashboard depth — terrain they own with years of customer data — Vim bypassed to the EHR-embedded point-of-care workflow layer that incumbents had not built, because their business model assumed physicians would log into a separate portal.
GROWTH ENGINE
GTM
ge n gtm
Partnership Growth, API Ecosystem Growth
Each EHR integration certification creates a new distribution channel that health plans activate for their physician networks. Each health plan customer that deploys Vim is simultaneously a distribution event and a reference customer for the next prospect.
- Direct enterprise sales to health plan medical directors led by former payer executives who speak quality-measure and Star Rating fluency.
- EHR certification partnerships (Epic App Orchard) as regulated distribution channels.
- Conference presence at AHIP, ViVE, and HLTH targeting health plan and value-based care decision-makers.
- Outcomes-based case studies published as primary sales collateral.
SUSTAINING MOATS
Switching Costs, High Customer Lock-In, Brand Power, Technology Advantage (complex enterprise scenarios)
moat
EHR integration certifications take 12–18 months to obtain — a barrier preventing underfunded competitors from simply replicating the embedded workflow approach. Once a health plan has deployed Vim across its physician network and integrated its quality-measure data feeds, replacing the tool requires re-training physicians, re-certifying a new vendor, and migrating historical performance data.
| MOAT INTELLIGENCE
THE STANDARD: In healthcare the moat is being present at the moment of clinical decision without asking anyone to change systems.
RULE 1 — WORKING INSIDE THE EXISTING EHR IS THE ENTIRE WEDGE. Clinicians will not adopt another application. Delivering insight into the workflow they already use removes the adoption barrier that kills most healthcare software.
RULE 2 — YOU ARE PAID BY THE PAYER AND USED BY THE PROVIDER. Health plans fund the technology to close care gaps and improve risk capture; physicians experience it as an interruption. Aligning those interests is the product problem.
RULE 3 — CARE GAP CLOSURE AND CODING ACCURACY HAVE DIRECT FINANCIAL VALUE, which is why this is one of the few healthcare categories with a clean return calculation.
THE SIGNAL: an integration layer sitting between payers and record systems is valuable to both and defensible against neither. The strategic question is whether you are building to be acquired by one side — because a middle layer rarely stays independent.
Why this company remains defensible
ARR & TAKEAWAY
ARR Journey - what to do at each stage
PRE-$1M ARR — DELIVER INSIGHT INSIDE THE EHR, NOT BESIDE IT
Clinicians will not open a second application during a visit. Surfacing gaps, referrals and cost guidance inside the record they already use is the entire proposition.
Sell to health plans and risk-bearing organisations, who have budget and measurable outcomes.
$1–5M ARR — CONNECTING TO EHRs IS THE MOAT AND THE WORK
Integration across many electronic record systems is slow, unglamorous and exactly what nobody else wants to do.
WATCH: clinician actions taken in-workflow, not recommendations displayed.
$5–10M ARR — PRICE ON OUTCOMES THE PAYER ALREADY MEASURES
Quality-gap closure, referral steerage and coding accuracy are line items in a payer's own reporting.
$10–50M ARR — THE MIDDLE-LAYER POSITION IS BOTH MOAT AND RISK
You depend on the EHR vendors whose surface you occupy. Their terms can change unilaterally.
NOTE: no ARR disclosed; reported funding varies by source.
$50–100M ARR — THE PLATFORMS AND PAYERS ARE THE ACQUIRERS
A neutral connectivity layer across competing record systems is precisely what a platform struggles to build itself.
$100M+ ARR — NOT CONFIRMED
Rule: in healthcare, distribution is the workflow. Whoever reaches the clinician without adding a click wins, and that integration burden is the barrier worth carrying.
COPY PLAYBOOK : What Worked → What Failed → What to Replicate → What to Avoid
THE STANDARD: When the end user has no purchasing power, sell the party who funds their adoption — and deliver inside the system the end user already uses.
SEQUENCE:
1. Identify who pays for the end user's behaviour change; sell them.
2. Deliver inside the incumbent workflow so the end user adopts nothing new.
3. Prove outcomes in the payer's own metrics, not the user's satisfaction.
WORKED: A B2B2C motion where the funder pays for deployment into the practitioner's existing environment — zero new habits required.
CAUTION:
1. THESE SALES CYCLES RUN 12-24 MONTHS ACROSS MULTIPLE APPROVAL BODIES. A company with thin runway cannot afford this motion, however good the product.
2. THE END USER WITH NO PURCHASING POWER STILL HAS VETO POWER through non-adoption.
bottom of page